vTv Therapeutics Inc. today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a subsidiary of CinRx Pharma, LLC (“CinRx”).
Menu
vTv Therapeutics Inc. today announced entry into agreements that include a $10 million investment by CinPax, LLC (“CinPax”), a subsidiary of CinRx Pharma, LLC (“CinRx”).
CinDome Pharma announced the negative results of a clinical thorough QT/QTc study of CIN-102.
CinFina Pharma announced that it has signed an agreement with Janssen Sciences.
